Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diane D Wang

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Journal of Clinical Pharmacology|January 25, 2011
Standardized visual predictive check versus visual predictive check for model evaluationDiane D Wang, Shuzhong Zhang
Clinical Pharmacology and Therapeutics|December 30, 2025
Optimizing Body Size-Based Dosing Approaches for Antibody-Drug ConjugatesAndrew B SyBing, Diane D Wang
Acta Pharmacologica Sinica|September 25, 2012
Clinical pharmacology considerations in biologics developmentLiang Zhao, Tian-hua Ren, Diane D Wang
Clinical Pharmacology and Therapeutics|August 16, 2025
Re-Evaluation of Fixed Dosing Versus Body Size-Based Dosing Approaches for Large Molecule Therapeutics in AdultsAndrew B SyBing, Huili Chen, Diane D Wang
Journal of Clinical Pharmacology|September 7, 2019
Population Pharmacokinetics of Talazoparib in Patients With Advanced CancerYanke Yu, Chandrasekar Durairaj, Haihong Shi, et al.
Clinical Pharmacokinetics|February 14, 2020
Effect of P-glycoprotein (P-gp) Inducers on Exposure of P-gp Substrates: Review of Clinical Drug-Drug Interaction StudiesMohamed Elmeliegy, Manoli Vourvahis, Cen Guo, et al.
Cancer Chemotherapy and Pharmacology|February 17, 2017
Effect of food on the bioavailability of palbociclibAna Ruiz-Garcia, Anna Plotka, Melissa O'Gorman, et al.
Journal of Clinical Pharmacology|January 15, 2011
Fixed dosing versus body size-based dosing of therapeutic peptides and proteins in adultsShuzhong Zhang, Rong Shi, Chunze Li, et al.
Clinical Pharmacology and Therapeutics|December 6, 2021
Analysis of US Food and Drug Administration Oncology Approvals on the Characterization of Hepatic Impairment Effect and Dosing RecommendationsDerek Z Yang, Ali Alhadab, Kourosh Parivar, et al.
Critical Reviews in Oncology/Hematology|January 21, 2023
Optimizing benefit/risk in oncology: Review of post-marketing dose optimization and reflections on the road aheadPooneh Soltantabar, Hoi-Kei Lon, Kourosh Parivar, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Journal of Clinical Pharmacology|January 25, 2011
Standardized visual predictive check versus visual predictive check for model evaluationDiane D Wang, Shuzhong Zhang
Clinical Pharmacology and Therapeutics|December 30, 2025
Optimizing Body Size-Based Dosing Approaches for Antibody-Drug ConjugatesAndrew B SyBing, Diane D Wang
Acta Pharmacologica Sinica|September 25, 2012
Clinical pharmacology considerations in biologics developmentLiang Zhao, Tian-hua Ren, Diane D Wang
Clinical Pharmacology and Therapeutics|August 16, 2025
Re-Evaluation of Fixed Dosing Versus Body Size-Based Dosing Approaches for Large Molecule Therapeutics in AdultsAndrew B SyBing, Huili Chen, Diane D Wang
Journal of Clinical Pharmacology|September 7, 2019
Population Pharmacokinetics of Talazoparib in Patients With Advanced CancerYanke Yu, Chandrasekar Durairaj, Haihong Shi, et al.
Clinical Pharmacokinetics|February 14, 2020
Effect of P-glycoprotein (P-gp) Inducers on Exposure of P-gp Substrates: Review of Clinical Drug-Drug Interaction StudiesMohamed Elmeliegy, Manoli Vourvahis, Cen Guo, et al.
Cancer Chemotherapy and Pharmacology|February 17, 2017
Effect of food on the bioavailability of palbociclibAna Ruiz-Garcia, Anna Plotka, Melissa O'Gorman, et al.
Journal of Clinical Pharmacology|January 15, 2011
Fixed dosing versus body size-based dosing of therapeutic peptides and proteins in adultsShuzhong Zhang, Rong Shi, Chunze Li, et al.
Clinical Pharmacology and Therapeutics|December 6, 2021
Analysis of US Food and Drug Administration Oncology Approvals on the Characterization of Hepatic Impairment Effect and Dosing RecommendationsDerek Z Yang, Ali Alhadab, Kourosh Parivar, et al.
Critical Reviews in Oncology/Hematology|January 21, 2023
Optimizing benefit/risk in oncology: Review of post-marketing dose optimization and reflections on the road aheadPooneh Soltantabar, Hoi-Kei Lon, Kourosh Parivar, et al.
Pageof 3